Toshiba America Medical Systems has received Food and Drug Administration 510(k) marketing clearance for its Infinix VC-i system with a large field-of-view (LFOV) 12 x 16-inch flat panel detector (FPD), according to the Tustin, CA-based vendor.
The Infinix VC-i system with LFOV FPD is Toshiba's newest angiography platform for vascular exams and interventional procedures. The company will showcase the product at the RSNA conference in Chicago next week.
By AuntMinnie.com staff writers
November 22, 2005
Related Reading
Toshiba brings Vantage to Europe, November 21, 2005
Road to RSNA, Toshiba America Medical Systems, November 10, 2005
Road to RSNA, Toshiba America Medical Systems, November 9, 2005
Road to RSNA, Toshiba America Medical Systems, November 8, 2005
Toshiba provides Aplio CV ultrasound for Johns Hopkins trial, November 7, 2005
Copyright © 2005 AuntMinnie.com














![Representative example of a 16-year-old male patient with underlying X-linked adrenoleukodystrophy. (A, B) Paired anteroposterior (AP) chest radiograph and dual-energy x-ray absorptiometry (DXA) report shows lumbar spine (L1 through L4) areal bone mineral density (BMD). The DXA report was reformatted for anonymization and improved readability. The patient had low BMD (Z score ≤ −2.0). (C) Model (chest radiography [CXR]–BMD) output shows the predicted raw BMD and Z score in comparison with the DXA reference standard, together with interpretability analyses using Shapley additive explanations (SHAP) and gradient-weighted class activation maps. The patient was classified as having low BMD, consistent with the reference standard. AM = age-matched, DEXA = dual-energy x-ray absorptiometry, RM2 = room 2, SNUH = Seoul National University Hospital, YA = young adult.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/ai-children-bone-density.0snnf2EJjr.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)



